Advanced age-related macular degeneration (AMD), the leading cause of blindness among people over 50 years of age, is characterized by atrophic neurodegeneration or pathologic angiogenesis. Early AMD is characterized by extracellular cholesterol-rich deposits underneath the retinal pigment epithelium (RPE) called drusen or in the subretinal space called subretinal drusenoid deposits (SDD) that drive disease progression. However, mechanisms of drusen and SDD biogenesis remain poorly understood. Although human AMD is characterized by abnormalities in cholesterol homeostasis and shares phenotypic features with atherosclerosis, it is unclear whether systemic immunity or local tissue metabolism regulates this homeostasis. Here, we demonstrate that targeted deletion of macrophage cholesterol ABC transporters A1 (ABCA1) and -G1 (ABCG1) leads to ageassociated extracellular cholesterol-rich deposits underneath the neurosensory retina similar to SDD seen in early human AMD. These mice also develop impaired dark adaptation, a cardinal feature of RPE cell dysfunction seen in human AMD patients even before central vision is affected. Subretinal deposits in these mice progressively worsen with age, with concomitant accumulation of cholesterol metabolites including several oxysterols and cholesterol esters causing lipotoxicity that manifests as photoreceptor dysfunction and neurodegeneration. These findings suggest that impaired macrophage cholesterol transport initiates several key elements of early human AMD, demonstrating the importance of systemic immunity and aging in promoting disease manifestation. Polymorphisms in genes involved with cholesterol transport and homeostasis […] 
Introduction
Age-related macular degeneration (AMD) is the leading cause of blindness among people over 50 years of age in the industrialized world (1) . Early disease is characterized by cholesterol-rich extracellular deposits underneath the retinal pigment epithelium (RPE) called drusen (2) (3) (4) or in the subretinal space called subretinal drusenoid deposits (SDD) (5) (6) (7) . The composition of these deposits is similar to that of atherosclerotic plaques (3) . AMD shares several phenotypic characteristics with atherosclerosis, including monocytic inflammation, pathologic angiogenesis, and genetic abnormalities in cholesterol homeostasis (4, 8) . Although the molecular mechanisms underlying pathological angiogenesis or RPE atrophy in advanced disease are better understood, there is a paucity of animal models that have been able to recapitulate early human disease -including anatomic features such as thickening of Bruch's membrane (BrM; an acellular lamina underneath the RPE), drusen, or SDD -or functional characteristics such as an association with age, rod photoreceptor dysfunction (9, 10), or impaired dark adaptation (11, 12) .
Advanced age-related macular degeneration (AMD), the leading cause of blindness among people over 50 years of age, is characterized by atrophic neurodegeneration or pathologic angiogenesis. Early AMD is characterized by extracellular cholesterol-rich deposits underneath the retinal pigment epithelium (RPE) called drusen or in the subretinal space called subretinal drusenoid deposits (SDD) that drive disease progression. However, mechanisms of drusen and SDD biogenesis remain poorly understood. Although human AMD is characterized by abnormalities in cholesterol homeostasis and shares phenotypic features with atherosclerosis, it is unclear whether systemic immunity or local tissue metabolism regulates this homeostasis. Here, we demonstrate that targeted deletion of macrophage cholesterol ABC transporters A1 (ABCA1) and -G1 (ABCG1) leads to age-associated extracellular cholesterol-rich deposits underneath the neurosensory retina similar to SDD seen in early human AMD. These mice also develop impaired dark adaptation, a cardinal feature of RPE cell dysfunction seen in human AMD patients even before central vision is affected. Subretinal deposits in these mice progressively worsen with age, with concomitant accumulation of cholesterol metabolites including several oxysterols and cholesterol esters causing lipotoxicity that manifests as photoreceptor dysfunction and neurodegeneration. These findings suggest that impaired macrophage cholesterol transport initiates several key elements of early human AMD, demonstrating the importance of systemic immunity and aging in promoting disease manifestation. Polymorphisms in genes involved with cholesterol transport and homeostasis are associated with a significantly higher risk of developing AMD, thus making these studies translationally relevant by identifying potential targets for therapy.
A number of genome-wide association studies (GWAS) have linked AMD to polymorphisms in genes involved in many facets of cholesterol homeostasis such as LIPC, ApoE, ABCA1, and CETP (13, 14) . In addition, widespread systemic disturbances in cholesterol metabolism as manifested by altered levels of lipoprotein subtypes have also been associated with AMD (15) . Despite reports implicating disruptions in cholesterol homeostasis in mouse models and in human AMD pathogenesis, it has not been established whether it is the systemic immune system or local "eye" cells that regulate cholesterol clearance and the development of the early AMD phenotype. Here, we demonstrate that, in conditional KO mice wherein both Abca1 and Abcg1 are deleted in macrophages, there is an age-dependent manifestation of several anatomic and functional AMD disease phenotypes, indicating that cholesterol clearance by macrophages plays a critical role in the early stages of AMD pathogenesis.
Numerous studies have demonstrated that cellular and humoral components of the innate immune system including macrophages, mononuclear phagocytes, and complement proteins contribute to both the development and severity of AMD (16) (17) (18) (19) . Macrophages not only function as antigen-presenting cells and phagocytic sensors of danger, but they are also important in cholesterol regulation by removing cholesterol from peripheral tissues and transporting it back to the liver through the bloodstream. This process is termed cholesterol efflux or reverse cholesterol transport (RCT) (3), and ABCA1 and ABCG1 play crucial roles in macrophage RCT by effluxing cholesterol from cells to extracellular carriers such as ApoA1 and HDL, respectively (20) . In this study, we generated conditional KO mice wherein both Abca1 and Abcg1 are deleted in macrophages. We evaluated the retinas structurally by biomicroscopy, histology, and electron microscopy (EM) at 3-12 months of age. In addition, we evaluated retinal function by electrophysiology. Figure 1H ), we suspected that ABCG1 might compensate for ABCA1, as both ABCA1 and ABCG1 play crucial roles in macrophage RCT by effluxing cholesterol to extracellular carriers (20) . For this reason, and to directly test whether macrophage cholesterol transport regulates the early AMD phenotype, we generated conditional KO mice wherein both Abca1 and Abcg1 are deleted in macrophages by crossing Figure  2A) . We also confirmed that these mice did not carry the Crb1 gene rd8 mutation (22) Figure 2B) , consistent with decreased cholesterol efflux in Abca1/g1 -m/-m macrophages and confirming findings from previous studies (17, 23) . However, functional analysis at 3 months of age demonstrated that both scotopic and photopic retinal responses (Figure 1 , A-C) and dark adaptation curves recorded from Abca1/g1 -m/-m mice retinas were normal ( Figure 1D ). In addition, in vivo imaging and histological examination of retinal sections of Abca1/g1 -m/-m mice did not show any substantial differences ( Figure 1 , E and F). These results suggest that deletion of both ABCA1 and ABCG1 in macrophages does not affect retinal function, vision, or morphology acutely or at a young age.
Results

Deletion of Abca1 and Abcg1 in macrophages does
Abca1/g1 -m/-m mice demonstrate RPE abnormalities, BrM thickening, and impaired dark adaptation at 6 months of age. In order to simulate the human condition, we aged Abca1/g1 -m/-m mice and their littermate controls. Upon analysis at 6 months age, we found that scotopic a-waveforms were now slightly attenuated in Abca1/g1 -m/-m retinas compared with littermate controls, confirming scotopic rod photoreceptor dysfunction (Figure 2 -m/-m mice (Figure 5, A and B) . Increased Iba1 expression was also confirmed in the retina/RPE/choroid complex of Figure 6C ). These findings demonstrate that the SD and lipids within RPE are composed of cholesterol and cholesterol esters, as well as cholesterol oxidation products that suggest a highly oxidative environment within the lipid deposits. 
Discussion
Here, we have demonstrated that, in conditional KO mice wherein macrophage cholesterol efflux capacities are disabled (Abca1/g1
-m/-m ), there is an age-dependent manifestation of several early and intermediate anatomic AMD disease phenotypes, including cellular and noncellular SD similar to SDD, increased BrM thickening, and accumulation of free cholesterol, cholesterol metabolites, and cholesteryl esters. In addition, KO mice demonstrate several key features of early functional degradation seen in human AMD, including impaired dark adaptation and rod photoreceptor dysfunction.
Although we generated macrophage-specific conditional KO mice by crossing Abca1 fl/fl and Abcg1 fl/fl mice with LysM-Cre mice, it has been established that LysM-Cre promotes significant deletion not only in macrophages, but also in neutrophils (24) . A previous study demonstrated variable deletion of Abca1 and Abcg1 in neutrophils (25) . Thus, we cannot exclude the possibility that the deletion of Abca1 and Abcg1 in neutrophils might also affect the retinal phenotype. However, in addition to the fact that macrophages, but not neutrophils, play crucial roles in RCT from tissues, we demonstrated increased gene expression of macrophage markers Iba1 and F4/80, but not the neutrophil marker Gr-1, in the eyes of 12-month-old Abca1/g1 -m/-m mice (Supplemental Figure 4) . For these reasons, we conclude that the retinal phenotypes we observed at 12 months of age are mainly associated with dysfunctional Abca1-and Abcg1-deficient macrophages, although further study might elucidate this more precisely. Polymorphisms in genes involved with cholesterol transport and homeostasis are associated with a significantly higher risk of developing AMD (13, 14) , thus making these studies translationally relevant by identifying potential targets for therapy. Although there are no previous reports of ABCG1 polymorphisms associated with increased AMD risk, we found that, in Abca1 -m/-m mice, ABCG1 might compensate for the lack of ABCA1. As such, we wanted to effectively neutralize the efflux pathway by the deletion of both Abca1 and Abcg1 in order to examine its effect on the retinal phenotype with aging.
We are also aware that ABCA1 polymorphisms associated with AMD risk are HDL elevating (26) (27) (28) (29) (30) . HDL carrier capacity is not just limited by level but by the size and quality of the particles available at the retinal choroidal interphase. In addition, these findings also suggest that there is a complex interplay between systemic lipid profiles and local lipid profiles in AMD.
Although we are proposing our mouse model as an early-stage AMD model, an important feature of AMD that is lacking in this model is the development of sub-RPE drusen and may represent metabolic differences between the mouse and human retina and RPE. However, although our mouse model (Abca1/g1
-m/-m mice) does not demonstrate all the features of human disease, age is a key variable here, just as in human AMD that only affects people over the age of 50 years. Thus, these findings suggest that maintenance of cholesterol homeostasis and macrophage-mediated cholesterol efflux may be critical pathways that initiate the development of AMD. These pathways deserve further investigation in order to determine whether pharmacotherapeutic interventions targeting these pathways, either locally or systemically, might prove efficacious in either preventing the development of early AMD or the progression to advanced stages of disease where vision loss is imminent. 
Methods
Supplemental Methods are available online with this article.
Animals. All mice were housed in a temperature-controlled room under a 12-hour light/dark cycle, with free access to food and water. ) mice were previously characterized (23) and were purchased commercially (The Jackson Laboratory). To generate mice lacking both Abca1 and Abcg1 specifically from macrophages, we crossed Abca1/g1 F/F mice with mice carrying 1 copy of the LysM-Cre transgene, which were purchased commercially (The Jackson Laboratory) and have been previously characterized (17, 21, 23) .
RNA isolation and qPCR. Total RNA was extracted using RNeasy Micro Plus kit (Qiagen) according to the manufacturer's instructions. To synthesize cDNA, total RNA was added to the High Capacity cDNA Reverse Transcription Kit (Thermo Fisher Scientific) and reverse-transcribed according to manufacturer's Analyses of free cholesterol, 3β,5α,6β-cholestanetriol (C-triol), 4β-hydroxycholesterol (4β-HC), 24-hydroxycholesterol (24-HC), 25-HC, 27-HC, and 7-ketocholesterol in retina/RPE/choroid complex at 12 months of age (normalized peak area ratio/mg wet tissue weight). Abca1/g1 F/F , n = 7; Abca1/g1 -m/-m , n = 6. *P < 0.05 and **P < 0.01 by 2-tailed unpaired t test. (C) Analyses of cholesterol esters (CE) in retina/RPE/choroid complex at 12 months of age (normalized peak area ratio/mg wet tissue weight). Abca1/g1 F/F , n = 7; Abca1/g1 -m/-m , n = 6. **P < 0.01 and ***P < 0.001 by 2-tailed unpaired t test. Values are mean ± SEM.
instructions. qPCR was performed in duplicate using the StepOnePlus Real Time PCR system (Thermo Fisher Scientific) using TaqMan Real-Time PCR Assays (Thermo Fisher Scientific), and the mRNA was quantified using the ΔΔCT method with gapdh or bactin as the internal control. Transmission EM. We performed transmission EM as previously described (31) . Briefly, for ultrastructural analyses, samples were fixed in 2% paraformaldehyde (PFA)/2.5% glutaraldehyde (Polysciences Inc.) in 100 mM sodium cacodylate buffer, pH 7.2, for 2 hours at room temperature and then overnight at 4°C. Samples were washed in sodium cacodylate buffer at room temperature and postfixed in 1% osmium tetroxide (Polysciences Inc.) for 1 hour. Samples were then rinsed extensively in dH 2 0 prior to en bloc staining with 1% aqueous uranyl acetate (Ted Pella Inc.) for 1 hour. Following several rinses in dH 2 O, samples were dehydrated in a graded series of ethanol and embedded in Eponate 12 resin (Ted Pella Inc.). Sections of 95 nm were cut with a Leica Ultracut UCT ultramicrotome (Leica Microsystems Inc.), stained with uranyl acetate and lead citrate, and viewed on a JEOL 1200 EX transmission electron microscope (JEOL USA Inc.) equipped with an AMT 8 megapixel digital camera and AMT Image Capture Engine V602 software (Advanced Microscopy Techniques).
To measure BrM thickness, we used 25,000× EM pictures. We set 5 measurement points that were arranged at equal 500-nm intervals and measured BrM thickness using Adobe Photoshop CS 5.1 (Adobe). We took averages of each picture as representative BrM thickness.
Electroretinography (ERG) . ERG was performed as previously described (32) . Briefly, A UTAS BigShot System (LKC Technologies Inc.) was used. Mice were dark adapted overnight. Under red light illumination, mice were anesthetized with an i.p. injection of 86.9 mg/kg ketamine and 13.4 mg/kg xylazine. Pupils were dilated with 1% atropine sulfate eye drops (Bausch & Lomb). Body temperature was maintained at 37°C with a heating pad. Contact lens electrodes were placed bilaterally with appropriate reference and ground electrodes. The stimulus consisted of a full-field white light flash (10 μs) in darkness or in the presence of dim (30.0 candela [cd]/m 2 ) background illumination after 10-minute adaptation time. Raw data were processed using MATLAB software (MathWorks). The amplitude of the a-wave was measured from the average pretrial baseline to the most negative point of the average trace, and the b-wave amplitude was measured from that point to the highest positive point.
For testing dark adaptation, we modified the protocol as previously described (33) . Briefly, we used a UTAS BigShot System (LKC Technologies Inc.) to get scotopic a-waves. A bright LED light (150,000 lux) was applied to both eyes for 15 seconds to photobleach an estimated 90% of the visual pigment. The recovery of the ERG responses was monitored at fixed post-bleach time points within 100 minutes after the bleach. The sensitivity was calculated as the ratio of dim flash response amplitude and the corresponding flash intensity in the linear range of the intensity-response curve. The post-bleach sensitivities were normalized to their dark-adapted prebleach level.
Retinal imaging. We performed digital color fundus photography and OCT as previously described (21) using the Micron III animal fundus camera equipped with 830 nm OCT (Phoenix Research Labs). Prior to fundus imaging and OCT, we anesthetized mice with an i.p. injection of 86.9 mg/kg ketamine and 13.4 mg/kg xylazine and administered 1.0% tropicamide eye drops (Bausch & Lomb) to dilate the pupils.
Cryopreservation. Enucleated posterior poles were fixed in 4% PFA followed by cryopreservation in Tissue-Tek OCT compound (Sakura Finetek). Cryosections (10-μm thick) were cut and collected on gelatin-coated slides and stored at -20°C until use.
ORO staining. ORO (0.7%, MilliporeSigma) staining solution was prepared in 100% propylene glycol (MilliporeSigma) by heating the solution to 90°C. The staining protocol was as follows. Slides were rinsed with water and placed in 100% propylene glycol for 5 minutes, followed by staining overnight in preheated (60°C) ORO solution. Slides were next differentiated in 85% propylene glycol for 1 minute at room temperature, followed by 2 rinses in water. Slides were dried at room temperature, mounted in Aqua-Poly/ Mount (Polysciences Inc.), and imaged using a ZEISS Axionplan 2 light microscope.
IHC. Retinal cryosections were incubated with a blocking solution of 10% normal goat serum (NGS) in PBTA (PBS, 0.5% BSA, 0.1% Triton, 0.05% Sodium Azide) for 2 hours at room temperature. After the blocking, sections were probed with either anti-Iba1 (Wako, catalog 019-19741; 1:200 in 10% NGS-PBTA) or anti-F4/80 antibodies (Bio-Rad, catalog MCA497GA; 1:500 in 10% NGS-PBTA) overnight at 4 °C. The next day, anti-Iba1 sections were incubated in goat anti-rabbit-568 (Thermo Fisher Scientific, catalog A11011; 1:200 in 5% NGS-PBTA) and anti-F4/80 sections were incubated in goat anti-rat-568 (Thermo Fisher Scientific, catalog A11077; 1:200 in 5% NGS-PBTA), both for 2 hours at room temperature. Nuclei were counterstained with DAPI (MilliporeSigma). All sections were examined under a confocal microscope equipped with a digital camera (C2si confocal microscope, Nikon Corporation). To count Iba1-or F4/80-positive cells in the subretinal space, 3 slides per animal were stained with Iba1 and F4/80, and 3 equidistant fields of view were identified in the nasal, central, and temporal regions, per slide. The number of staining positive cells were counted in each field of view and their mean was taken (n). The n values from 3 slide were averaged as cell counts/field in the subretinal space.
Analyses of oxysterols, free cholesterol, and cholesterol esters in retina/RPE/choroid complex. Each retina/ RPE/choroid complex was homogenized with 50-fold excess volume of PBS buffer using Omni Bead Ruptor 24 (Omni International Inc.). All analytes listed above in 50 μl of the mouse retina homogenate were extracted with 200 μl of methanol. Prior to the extraction, triol-d7 (2 ng), 7-ketocholesterol-d7 (2 ng), 24-hydroxycholesterol-d7 (24-HC-d7; 2 ng), 27-HC-d5 (2 ng), 4β-HC-d7 (2 ng), cholesterol esters (18:2)-d7 (CE[18:2]-d7;200 ng), and cholesterol-d7 (1 μg) were added as the internal standards to the homogenate samples. All oxysterols and cholesterol, as well as their deuterated standards, were derivatized with N,N-dimethylglycine (DMG) to increase the MS sensitivity. Cholesterol esters were not derivatized for the MS analyses.
Oxysterol analysis was performed with a Shimadzu 20AD HPLC system and a Shimadzu SIL 20AC autosampler coupled to a triple quadrupole mass spectrometer (API-6500Qtrap+, Thermo Fisher Scientific) operated in multiple reaction monitoring (MRM) mode. The positive ion electrospray ionization (ESI) mode was used for detection of the DMG derivatized oxysterols. All samples were injected in duplicate for data averaging. Data processing was conducted with Analyst 1.6.3 (Thermo Fisher Scientific).
The analysis of free cholesterol and 2 CEs (CE [16:0] and CE [18:0] ) was performed with a Shimadzu 20AD HPLC system: a LeapPAL autosampler coupled to a triple quadrupole mass spectrometer (API 4000) operated with positive ion MRM mode. The data processing was conducted with Analyst 1.5.1 (Thermo Fisher Scientific).
The analysis of the rest of the CEs (CE [16:2] , CE [18:1] , CE [18:2] , and CE [20:4] ) was performed with a Shimadzu 10AD HPLC system and a Shimadzu SIL 20AC autosampler coupled to a triple quadrupole mass spectrometer (TSQ Quantum Ultra) operated in MRM mode. The data processing was conducted with XCalibur.
The relative quantification data is reported as peak area ratios of analytes to their internal standards normalized to wet weights (mg) of retina/RPE/choroid complex.
Statistics. We performed statistical testing with GraphPad Prism (Version 6.0), using the appropriate test for each dataset (2-way ANOVA, 2-way ANOVA with post hoc Bonferroni's multiple comparison test, 2-tailed unpaired t test, or 2-tailed Mann-Whitney U test). We defined statistical significance as a P < 0.05. Values are mean ± SEM.
Study approval. All animal experiments were reviewed and approved by the IACUC of Washington University in St. Louis and performed in accordance with the Washington University School of Medicine Animal Care and Use guidelines.
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